The invention discloses a new application of human YTHDF1, namely an application of a human YTHDF1
gene expression quantity detection
reagent in preparation of a prostatic
cancer clinical diagnosis reagent. The expression of the human YTHDF1
gene in prostatic
cancer tissues and
cell lines is increased; after the expression of the YTHDF1
gene is knocked down, the growth of a
prostate cancer cell line, the culture of organoids and the growth of transplanted tumors in nude mice are obviously inhibited; according to the present invention, with the application of the RNF7 in the
tumor cells, the proliferation of the normal
prostate epithelial cells can be promoted by the overexpression, the
protein level of the RNF7 in the YTHDF1 knocked-down cells is significantly inhibited, the
phenotype of the YTHDF1 knocked-down cells can be rescued by the overexpression of the RNF7, and the sensitivity of the
tumor cells to the
chemotherapeutic drugs can be promoted by the YTHDF1 knocked-down cells so as to promote the
apoptosis; the prostatic cancer can be treated by inhibiting expression drugs of the human YTHDF1 gene, inhibiting expression of the E3
ubiquitin ligase RNF7 gene or screening drugs for degrading the E3
ubiquitin ligase RNF7.